January 19-21, 2007 ASCO
Gastrointestinal Cancer Symposium, Orlando, Florida
Dr. Jean Maroun, Medical
Oncologist, Ottawa Regional Cancer Centre
Dr. Sharlene Gill, Medical
Oncologist, British Columbia Cancer Agency
Dr. Derek Jonker, Medical
Oncologist, The Ottawa Hospital Regional Cancer Centre
Les grands enjeux issus de la réunion annuelle 2003 de l'American Society of Clinical Oncology et de la 5ième conférence internationale: Perspectives en matière de cancer colorectal (PICC 2003)
Le Dr Jean Maroun, président
du comité de rédaction du portail web
Oncologie canadienne (COS) et oncologue au Ottawa
Regional Cancer Centre, Pierre Dube, md, FRCSC Chirurgien
Oncologue, Hôpital Maisonneuve-Rosemont, Professeur
Adjoint de Chirurgie, Université de Montréal,
Directeur du Laboratoire de Recherche et d’Enseignement
Chirurgical, Centre de Recherche Guy Bernier, et le
Dr Benoit Samson, FRCPC, Médecine Interne,
Oncologue Médicale à l’Hôpitale
Charles LeMoyne discutent des principaux enjeux qui
sont ressortis de la réunion annuelle 2003
de l’American Society of Clinical Oncology (ASCO)
et de la 5ième conférence internationale:
Perspectives en matière de cancer colorectal
(PICC 2003)
Major
issues in the treatment of colorectal cancer arising
from the Annual Meeting of the American Society
of Clinical Oncology 2003 and The 5th International
Conference: Perspectives in Colorectal Cancer (PICC
2003)
Dr. Jean Maroun, Chair of the Editorial Committee
of the Canadian Oncology website site and Medical
Oncologist with the Ottawa Regional Cancer Centre
and Medical Oncologist, Dr. Anthony Fields, President
of the National Cancer Institute of Canada (NCIC)
& Vice President, Medical Affairs and Community
Oncology, Alberta Cancer Board discuss and Dr. Ralph
Wong, Medical Oncologist CancerCare Manitoba, St.
Boniface General Hospital, review major issues arising
from the Annual Meeting of the American Society of
Clinical Oncology 2003 and The 5th International Conference:
Perspectives in Colorectal Cancer (PICC 2003) in Barcelona
pertaining to the treatment of colorectal cancer.
Once Weekly Epoetin Alfa Maintains
Hemoglobin, Improves Quality of
Life and Reduces Transfusion in
Breast Cancer Patients Receiving
Chemotherapy
For
the Canadian Eprex Study
Group
Jose Chang, Durham Regional
Cancer Centre, Oshawa, Ontario;
Félix
Couture Hôtel-Dieu
de Lévis,
Lévis,
Québec
and Hôtel-Dieu
de Québec,
Quebec City, Québec.
A
study
demonstrating
that
once
weekly
Epoetin
Alfa
maintains
hemoglobin,
improves
Quality
of
Life
and
Reduces
Transfusion
in
Breast
Cancer
Patients
Receiving
Chemotherapy.
Western
Canada Consensus Conference
on the Treatment of Colorectal
Cancer
In
Conversation with... Dr. Heather-Jane Au
Metastatic
colorectal cancer management
“The evidence available
supports sequential use of
infusional combination chemotherapy
regimens for the palliative
treatment of metastatic colorectal
cancer to achieve the best
outcomes for patients in whom
combination chemotherapy is
appropriate.”
FOLFIRI or Douillard
FOLFOX
